PCA3 in the detection and management of early prostate cancer. - Wikidata - wikimedia - TriplyDB

PCA3 in the detection and management of early prostate cancer.

PCA3 in the detection and management of early prostate cancer.

http://www.wikidata.org/entity/Q38090552

about

Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience Clinical significance of NUCB2 mRNA expression in prostate cancer.Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Molecular markers to guide primary radical treatment selection in localized prostate cancer.Long noncoding RNAs in liver cancer: what we know in 2014.Prostate cancer: a review of active surveillance.Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.Current biomarkers for diagnosing of prostate cancer.Long noncoding RNAs in lung cancer: what we know in 2015.Risk stratification of prostate cancer 2016.Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells.Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?Emerging biomarkers in the diagnosis of prostate cancer.

P2860

Q27001399-CAE1BB5E-3A8E-4970-A933-478FDA564419 Q28075610-2B59B602-B6BC-4049-8501-BDE0165B170C Q33568125-67FA9C05-E876-4C5A-A1EC-804387EAE2B6 Q35074229-E3E6520A-4318-4E06-A086-B9C3771F9E4F Q37116462-5C958F48-A7A0-4180-9770-F55F2E212919 Q37155070-5F6E2A60-BB5D-42C3-AB79-05041EFDB692 Q37367755-B4F82071-C3C9-4829-B8DC-E69B783E344A Q37644685-EBDD505E-8255-40F7-90E9-3B39D235EAED Q38216129-5BDD8679-2639-4DE6-90D6-66388C32655C Q38226242-6F867435-D1A1-42AB-AAFD-F2FF9DD1F038 Q38241983-1BE946A0-7CAA-4F5F-B8DC-26A13D7E8387 Q38247297-8F388788-D4F6-43C7-81EE-61AEDCA65B96 Q38568275-A20DEE6C-BE99-4076-BF1B-B099C4F6E467 Q38584370-04C56332-16CA-41B0-B84E-0F96BCD1D40F Q38672942-9A5BD4E2-C5E1-47A8-8BB3-3C8B624B5852 Q38929868-85D604F9-76A1-478C-8964-D331528A2BB3 Q41808633-668C8FEB-15E6-4637-8A40-B47CAAB9A4C4 Q48225109-AE7A153A-D8C5-498E-BEF4-EFF52A87F59D Q54964875-0E0BAB8A-B9DA-4AF2-AEA7-EA4DB8EA97A3

P2860

PCA3 in the detection and management of early prostate cancer.

http://www.wikidata.org/entity/Q38090552

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

PCA3 in the detection and management of early prostate cancer.

@en

type

label

PCA3 in the detection and management of early prostate cancer.

@en

prefLabel

PCA3 in the detection and management of early prostate cancer.

@en

P1433

Q38090552-AD84096A-E695-42E4-94A9-16EFCBD019C2

P1476

Q38090552-3EFD69F9-A62D-4BFA-B645-34350DF3F0A0

P2093

Q38090552-0C00699E-8F06-473B-972E-5CF50BF63811

Q38090552-131F3E7B-D12A-407E-8691-D22AB93FA765

Q38090552-7F4FDE94-8886-4C76-9F13-9F9870E68692

Q38090552-917ED54D-54F2-42AA-BA31-92A6BB173422

Q38090552-BD3C1633-14CD-4C49-A880-865413C0AF42

Q38090552-D398E0F9-88FD-4188-8242-63F74093B229

P2860

Q38090552-0A3E006B-FFCC-498D-9F97-A93EC30BB217

Q38090552-0C9381DA-A8AC-4B5B-98AC-AEAA6F920F5E

Q38090552-0FFF46A9-1A5E-43C8-87B9-E8CCEA0DDDC1

Q38090552-109AA089-BADD-4125-B47D-D39AFFC7C690

Q38090552-1795B31B-B6CC-4597-B0B9-25F7491A8B45

Q38090552-192F4E24-8FAD-43A8-BA7F-D54994B3CC53

Q38090552-1B550AC4-30A4-47BE-A6ED-8588AAC2B40E

Q38090552-209A1739-1B3D-42B3-9283-7992D2D94F6B

Q38090552-263ACDCA-03CA-4364-A0D2-C455660B8E8E

Q38090552-2D16E89E-6495-485F-9635-DD1B5E69A65A

P2888

Q38090552-3B117518-2E7A-4B97-8E50-7332C7A99E64

P304

Q38090552-611C5C0A-5625-4780-B433-32D720DD2BD9

P31

Q38090552-74589338-1CE9-47A4-A5F4-4FE34395D051

P356

Q38090552-09E18A0F-98BF-4D21-8EDF-8552D3839490

P433

Q38090552-25130F32-A2AC-47A9-B475-5FF57969426C

P478

Q38090552-1379C9E0-AD83-4E95-984E-B9235B61556F

P577

Q38090552-4E08DA1A-D653-4247-A956-0C728600C0CE

P6179

Q38090552-4E1D9443-212E-4018-8CE3-0EA22A46D326

P698

Q38090552-DE6D949D-E506-4687-93D4-277F5B675DA3

P356

S13277-013-0739-6

P1433

P1476

PCA3 in the detection and management of early prostate cancer.

@en

P2093

Josep M Augé

http://www.w3.org/2001/XMLSchema#string

Laura Foj

http://www.w3.org/2001/XMLSchema#string

Montserrat Milà

http://www.w3.org/2001/XMLSchema#string

Rafael Molina

http://www.w3.org/2001/XMLSchema#string

Wladimiro Jiménez

http://www.w3.org/2001/XMLSchema#string

Xavier Filella

http://www.w3.org/2001/XMLSchema#string

P2860

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.

[Assessment of the PCA3 test for prostate cancer diagnosis: a systematic review and meta-analysis]

Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test.

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.

PCA3: a molecular urine assay for predicting prostate biopsy outcome.

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.

P2888

s13277-013-0739-6

P304

1337-1347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-013-0739-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028433189

http://www.w3.org/2001/XMLSchema#string

P698

23504524

http://www.w3.org/2001/XMLSchema#string